Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Gastric Cancer
Clinical trial NCT00681577 · COMPLETED
Trial details
- NCT number
- NCT00681577
- Sponsor
- Tokyo University
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-05-01
- Primary completion
- 2009-10-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.